Yuyu Cefaclor Dry Syrup (Cefaclor Hydrate)
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Yuyu Pharmaceutical Co., Ltd.
MFDS item code 199400240 · Notified 1994.02.08
This product's status changed to Approval withdrawn on 2025.10.15. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of otitis media, respiratory (pneumonia, pharyngitis, etc.), and urinary tract infections (pyelonephritis, cystitis, etc.)
This medication is effective against various harmful bacteria such as Streptococcus pneumoniae, Influenza bacillus, Staphylococcus, and Escherichia coli, and is used for respiratory infections such as otitis media, pneumonia, pharyngitis, and bronchitis. It is also effective for urinary tract infections such as pyelonephritis, cystitis, and gonococcal urethritis. Additionally, it is used to treat skin-related infections such as boils, abscesses, folliculitis, soft tissue infections, infectious gangrene, subcutaneous abscesses, fresh skin wounds, and wound infections. It effectively improves various infectious diseases.
For Cefaclor, take 250mg (potency) every 8 hours orally. In cases of severe infections (such as pneumonia) and low susceptibility infections, the dosage may be doubled. In cases of acute gonococcal urethritis, co-administer this drug at 3g with probenecid at 1g in a single dose.
Administer 20mg (potency) per kg of body weight divided every 8 hours. In cases of severe infections, otitis media, and low susceptibility infections, 40mg (potency) per kg of body weight may be administered, with a maximum dosage of
This drug is an antibiotic that works by killing specific bacteria. It should not be used in patients who have ever experienced severe allergic reactions (shock) due to this drug, or in patients who are allergic to this drug or cephalosporin antibiotics. Moreover, this drug contains lactose and should not be administered to patients with genetic disorders that prevent lactose breakdown. Patients allergic to penicillin antibiotics or those with a predisposition to allergic symptoms such as asthma or skin rashes should use this drug with caution. Patients with severely impaired renal function, those who are ill-nourished or elderly, and patients with poor overall health should also use this drug cautiously and be carefully monitored for possible vitamin K deficiency symptoms. Patients with a history of gastrointestinal disorders, particularly colitis, should also be cautious when using this drug. Rarely, this drug can cause various side effects including severe allergic reactions, skin rashes, blood abnormalities, liver and kidney dysfunction, gastrointestinal issues, respiratory problems, and neurological abnormalities, so if symptoms occur, medical consultation should be sought immediately. If severe allergic reactions or skin disorders occur, administration should be discontinued immediately, and appropriate treatment should be received. When using this drug, it’s important to confirm the susceptibility of the infectious bacteria to prevent the emergence of resistant strains and to administer it only for the necessary duration. Also, since there are other drugs that interact with this drug, it is essential to inform healthcare providers of any concurrent medications, and patients on anticoagulants should undergo frequent blood tests as this drug can affect blood coagulation. Pregnant women or those who may become pregnant should carefully consider the risks and benefits of using this drug, and nursing women should also use it with caution. Safety for neonates under 1 month has not been established, and it is advisable not to use it in this population. Elderly patients may experience heightened adverse reactions due to decreased physical functions, so dosage and administration intervals should be adjusted, and careful observation is necessary. This drug may impact certain test results, so it is important to inform the healthcare provider about taking this drug during examinations.
Shock, anaphylactic symptoms (swelling, difficulty breathing), urticaria, Stevens-Johnson syndrome, toxic epidermal necrolysis, liver issues (including jaundice), acute renal failure, severe renal impairment, severe colitis including pseudomembranous colitis, interstitial pneumonia, eosinophilic lung infiltration, asthma attacks, difficulty breathing
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to light, so it should be stored in a tightly sealed container that blocks light. Additionally, it is important to maintain a storage temperature between 1 degree and 30 degrees to ensure the safety of the drug's efficacy.
Pink powdered syrup
150mL/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Yuyu Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Kolon Pharmaceutical Co., Ltd.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Cefaclor Hydrate 250mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Cefaclor Hydrate 2.5g
Syrup · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Cefaclor Hydrate 3.75g
Syrup · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.